30-day -Federal Register Notice- NRC Form 483

Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices

khammond on DSKJM1Z7X2PROD with NOTICES

departures from Tier 1 information in
the certified DCD incorporated by
reference in 10 CFR part 52, appendix
D, ‘‘Design Certification Rule for the
AP1000 Design,’’ as part of license
amendment request (LAR) 20–001,
‘‘Unit 3 Auxiliary Building Wall
Seismic Gap Requirements.’’
For the reasons set forth in Section 3.2
of the NRC staff’s Safety Evaluation, the
Commission finds that:
A. The exemption is authorized by
law;
B. the exemption presents no undue
risk to public health and safety;
C. the exemption is consistent with
the common defense and security;
D. special circumstances are present
in that the application of the rule in this
circumstance is not necessary to serve
the underlying purpose of the rule;
E. the special circumstances outweigh
any decrease in safety that may result
from the reduction in standardization
caused by the exemption; and
F. the exemption will not result in a
significant decrease in the level of safety
otherwise provided by the design.
2. Accordingly, SNC is granted an
exemption from the certified DCD Tier
1 information, with corresponding
changes to Appendix C of the facility
Combined License, as described in the
licensee’s request dated February 7,
2020. This exemption is related to, and
necessary for, the granting of License
Amendment No. 182, which is being
issued concurrently with this
exemption.
3. As explained in Section 6.0 of the
NRC staff’s Safety Evaluation, this
exemption meets the eligibility criteria
for categorical exclusion set forth in 10
CFR 51.22(c)(9). Therefore, pursuant to
10 CFR 51.22(b), no environmental
impact statement or environmental
assessment needs to be prepared in
connection with the issuance of the
exemption.
4. This exemption is effective as of the
date of its issuance.
III. License Amendment Request
By letter dated February 7, 2020, SNC
requested that the NRC amend COL
NPF–91 for VEGP Unit 3. The proposed
amendment is described in Section I of
this Federal Register notice.
The Commission has determined for
this amendment that the application
complies with the standards and
requirements of the Atomic Energy Act
of 1954, as amended (the Act), and the
Commission’s rules and regulations.
The Commission has made the findings
required by the Act and the
Commission’s rules and regulations in
10 CFR chapter I, which are set forth in
the license amendment.

VerDate Sep<11>2014

17:09 Jan 11, 2021

Jkt 253001

A notice of consideration of issuance
of amendment to the COL, proposed no
significant hazards consideration
determination, and opportunity for a
hearing in connection with this action,
was published in the Federal Register
on March 10, 2020 (85 FR 13944). No
comments were received during the 30day comment period.
The Commission has determined that
this amendment satisfies the criteria for
categorical exclusion in accordance
with 10 CFR 51.22. Therefore, pursuant
to 10 CFR 51.22(b), no environmental
impact statement or environmental
assessment need be prepared for this
amendment.
IV. Final No Significant Hazards
Consideration Determination
A request for hearing was filed on
May 11, 2020, by the Blue Ridge
Environmental Defense League and its
chapter, Concerned Citizens of Shell
Bluff (collectively ‘‘BREDL’’) (ADAMS
Package Accession No. ML20132D299).
Under its regulations, the Commission
may issue and make an amendment
immediately effective, notwithstanding
the pendency before it of a request for
a hearing from any person, in advance
of the holding and completion of any
required hearing, where it has made a
final determination that no significant
hazards consideration is involved.
While the hearing request was pending
before an Atomic Safety and Licensing
Board (ASLB), the NRC staff issued the
amendment on August 4, 2020, after
making a final determination that no
significant hazards consideration was
involved, as discussed in Section 4.0 of
the combined safety evaluation.
Subsequently, the ASLB denied
BREDL’s request for hearing and
terminated the proceeding in its order
LBP–20–08, dated August 10, 2020
(ADAMS Accession No. ML20223A385).
On September 4, 2020, BREDL appealed
the ASLB decision (ADAMS Accession
No. ML20248J166). On December 22,
2020, the Commission affirmed the
ASLB’s decision (ADAMS Accession
No. ML20357A101).
V. Conclusion
For the reasons set forth in the
combined safety evaluation, the staff
granted the exemption and issued the
amendment that SNC requested on
February 7, 2020. The exemption and
amendment were issued on August 4,
2020, as part of a combined package to
SNC (ADAMS Package Accession No.
ML20132A032).
Dated: January 7, 2021.

PO 00000

Frm 00086

Fmt 4703

Sfmt 4703

2465

For the Nuclear Regulatory Commission.
Omar R. Lopez-Santiago,
Chief, Vogtle Project Office, Office of Nuclear
Reactor Regulation.
[FR Doc. 2021–00410 Filed 1–11–21; 8:45 am]
BILLING CODE 7590–01–P

NUCLEAR REGULATORY
COMMISSION
[NRC–2020–0221]

Information Collection: NRC Form 483,
‘‘Registration Certificate—In Vitro
Testing with Byproduct Material Under
General License’’
Nuclear Regulatory
Commission.
ACTION: Notice of submission to the
Office of Management and Budget;
request for comment.
AGENCY:

The U.S. Nuclear Regulatory
Commission (NRC) has recently
submitted a request for renewal of an
existing collection of information to the
Office of Management and Budget
(OMB) for review. The information
collection is entitled, NRC Form 483,
‘‘Registration Certificate—In Vitro
Testing with Byproduct Material Under
General License.’’
DATES: Submit comments by February
11, 2021. Comments received after this
date will be considered if it is practical
to do so, but the Commission is able to
ensure consideration only for comments
received on or before this date.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to https://www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under Review—
Open for Public Comments’’ or by using
the search function.
FOR FURTHER INFORMATION CONTACT:
David Cullison, NRC Clearance Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
[email protected].
SUPPLEMENTARY INFORMATION:
SUMMARY:

I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2020–
0221 when contacting the NRC about
the availability of information for this
action. You may obtain publicly
available information related to this
action by any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov and search

E:\FR\FM\12JAN1.SGM

12JAN1

2466

Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices

khammond on DSKJM1Z7X2PROD with NOTICES

for Docket ID NRC–2020–0221. A copy
of the collection of information and
related instructions may be obtained
without charge by accessing Docket ID
NRC–2020–0221 on this website.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publicly
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, 301–
415–4737, or by email to pdr.resource@
nrc.gov. A copy of the collection of
information and related instructions
may be obtained without charge by
accessing ADAMS Accession No.
ML20205L413. The supporting
statement is available in ADAMS under
Accession No. ML20335A465.
• Attention: The PDR, where you may
examine and order copies of public
documents is currently closed. You may
submit your request to the PDR via
email at [email protected] or call 1–
800–397–4209 or 301–415–4737,
between 8:00 a.m. and 4:00 p.m. (EST),
Monday through Friday, except Federal
holidays.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting the NRC’s
Clearance Officer, David Cullison,
Office of the Chief Information Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
[email protected].
B. Submitting Comments
The NRC encourages electronic
comment submission through the
Federal Rulemaking website (https://
www.regulations.gov). Please include
Docket ID NRC–2020–0221 in your
comment submission.
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC will post all comment
submissions at https://
www.regulations.gov as well as enter the
comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the OMB, then you
should inform those persons not to
include identifying or contact
information that they do not want to be
publicly disclosed in their comment

VerDate Sep<11>2014

17:09 Jan 11, 2021

Jkt 253001

submission. Your request should state
that comment submissions are not
routinely edited to remove such
information before making the comment
submissions available to the public or
entering the comment into ADAMS.
II. Background
Under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35), the NRC recently
submitted a request for renewal of an
existing collection of information to
OMB for review entitled, NRC Form
483, ‘‘Registration Certificate—In Vitro
Testing with Byproduct Material Under
General License.’’ The NRC hereby
informs potential respondents that an
agency may not conduct or sponsor, and
that a person is not required to respond
to, a collection of information unless it
displays a currently valid OMB control
number.
The NRC published a Federal
Register notice with a 60-day comment
period on this information collection on
October 8, 2020 (85 FR 63591).
1. The title of the information
collection: NRC Form 483, ‘‘Registration
Certificate—In Vitro Testing with
Byproduct Material Under General
License.’’
2. OMB approval number: 3150–0038.
3. Type of submission: Extension.
4. The form number if applicable:
NRC Form 483.
5. How often the collection is required
or requested: There is a one-time
submittal of information to receive a
validated copy of the NRC Form 483
with an assigned registration number. In
addition, any changes in the
information reported on the NRC Form
483 must be reported in writing to the
NRC within 30 days after the effective
date of the change.
6. Who will be required or asked to
respond: Any physician, veterinarian in
the practice of veterinary medicine,
clinical laboratory, or hospital which
desires a general license to receive,
acquire, possess, transfer, or use
specified units of byproduct material in
certain in vitro clinical or laboratory
tests.
7. The estimated number of annual
responses: 6 responses.
8. The estimated number of annual
respondents: 6 respondents.
9. An estimate of the total number of
hours needed annually to comply with
the information collection requirement
or request: 1.12 hours.
10. Abstract: Section 31.11 of title 10
of the Code of Federal Regulations (10
CFR), established a general license
authorizing any physician, clinical
laboratory, veterinarian in the practice
of veterinary medicine, or hospital to

PO 00000

Frm 00087

Fmt 4703

Sfmt 4703

possess certain small quantities of
byproduct material for in vitro clinical
or laboratory tests not involving the
internal or external administration of
the byproduct material or the radiation
therefrom to human beings or animals.
Possession of byproduct material under
10 CFR 31.11 is not authorized until the
physician, clinical laboratory,
veterinarian in the practice of veterinary
medicine, or hospital has filed the NRC
Form 483 and received from the
Commission a validated copy of the
NRC Form 483 with a registration
number. The licensee can use the
validated copy of the NRC Form 483 to
obtain byproduct material from a
specifically licensed supplier. The NRC
incorporates this information into a
database which is used to verify that a
general licensee is authorized to receive
the byproduct material.
Dated: January 6, 2021.
For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief
Information Officer.
[FR Doc. 2021–00331 Filed 1–11–21; 8:45 am]
BILLING CODE 7590–01–P

SECURITIES AND EXCHANGE
COMMISSION
[Investment Company Act Release No.
34165; File No. 812–15066]

Symmetry Panoramic Trust and
Symmetry Partners, LLC
January 6, 2021.

Securities and Exchange
Commission (‘‘Commission’’).
ACTION: Notice.
AGENCY:

Notice of an application for an order
pursuant to: (a) Section 6(c) of the
Investment Company Act of 1940
(‘‘Act’’) granting an exemption from
sections 18(f) and 21(b) of the Act; (b)
section 12(d)(1)(J) of the Act granting an
exemption from section 12(d)(1) of the
Act; (c) sections 6(c) and 17(b) of the
Act granting an exemption from sections
17(a)(1), 17(a)(2) and 17(a)(3) of the Act;
and (d) section 17(d) of the Act and rule
17d–1 under the Act to permit certain
joint arrangements and transactions.
Applicants request an order that would
permit certain registered management
investment companies to participate in
a joint lending and borrowing facility.
Applicants: Symmetry Panoramic
Trust, a Delaware statutory trust
registered under the Act as an open-end
management investment company with
multiple series, and Symmetry Partners,
LLC (‘‘Symmetry Partners’’), a
Connecticut limited liability company

E:\FR\FM\12JAN1.SGM

12JAN1